Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Filings indexed 499 across all filing types
Latest filing 2020-05-14 Regulatory Filings
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2019-12-31
Regulatory Filings
2020-05-14 English
Non-Executive Director appointment
Board/Management Information Classification · 100% confidence The document begins with an 'RNS Number' and is dated May 11, 2020. The subject is the 'Non-Executive Director appointment' of Heather Mason. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management change, making MANG the most precise classification. The document length is relatively short (3084 chars), but it is the primary announcement itself, not an announcement *about* a report.
2020-05-11 English
AGM Results - Resolutions
AGM Information Classification · 100% confidence The document explicitly states that the content consists of 'Ordinary and Special Resolutions' passed at the 'Annual General Meeting' (AGM) of ConvaTec Group Plc on May 7, 2020. It details specific resolutions regarding directors' authority to allot shares (Resolution 17), disapplication of pre-emption rights (Resolutions 18 and 19), and market purchases of own shares (Resolution 20). This content is directly related to the formal proceedings and decisions made during the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R).
2020-05-07 English
Result of AGM
AGM Information Classification · 100% confidence The document explicitly states it contains the "Results of Annual General Meeting" and provides a detailed poll result table for various resolutions voted upon during the meeting (e.g., 'Receive Annual Report and Accounts', 'Elect John McAdam as a director'). This content directly corresponds to the definition of AGM Information. The RNS Number and the reference to the National Storage Mechanism confirm it is a formal regulatory disclosure related to the AGM.
2020-05-07 English
Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document is explicitly marked with 'RNS Number : 0031M' and contains the header 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This type of filing details share transactions by directors/executives (Karim Bitar and Frank Schulkes). This directly matches the definition for Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2020-05-05 English
ConvaTec Group Plc Q1 2020 Trading Update
Earnings Release Classification · 100% confidence The document begins with 'RNS Number : 3944L' and is dated April 30, 2020. It provides a 'Trading update for the three months ended 31 March 2020' including key financial highlights (revenue, growth rates) and an outlook update, which is characteristic of an Earnings Release (ER). However, the document is distributed via RNS, the news service of the London Stock Exchange, and the content itself is a summary of quarterly performance, not the full comprehensive report (which would be an IR). Since it is a formal announcement of period results, ER is the most appropriate classification. It is not a full transcript (CT), a full annual report (10-K), or a formal proxy/governance document. The presence of the RNS header suggests it is a regulatory announcement, but the content is specifically an earnings update. Q1 2020
2020-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.